Lapinig, Jhon Jhayden G.

HRN: 28-75-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2026
CEFUROXIME 750MG (VIAL)
03/26/2026
04/02/2026
IV
420mg
Q8
T/C UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: